Conversely, knockdown of TIMP2 showed a strong tendency to decrease migration and invasion in MCF-7, T47D, and SKBr-3 cells, with the magnitude of this effect varying between breast cancer cell lines. Here, TIMP2 is linked to breast carcinoma.